FDA has the regulatory authority to place a clinical trial on clinical hold if there is insufficient information provided in the Investigational Device Exemption (IDE) of Investigational New Drug (IND) application to show adequate safety of the trial. A clinical hold may also be placed on an ongoing trial if new information that raises questions of safety is obtained.
Share / Follow
TDM Assays The net under the safe and effective tightrope
Prenatal Group B Strep Tests Making the early days of life that much safer
Myocardial Infarction Panels Is it a heart attack, or just heartburn?
Pre- and Postnatal CF Screening Early detection = better prognosis
Investigational New Drug (IND)